Source: Times of India

NEW DELHI: Limited use of hydroxychloroquine (HCQ) for treatment of Covid-19 patients was allowed as it has proved to be clinically beneficial in small single centre studies, the Centre told Parliament on Tuesday, reports Mohua Chatterjee.

Junior health minister Ashwini Choubey was replying to a question on whether the government had accurate data regarding efficacy of HCQ .
The minister said, “The government has re-purposed the drug HCQ for treatment of mild (but high-risk cases) and for moderate cases. However, the drug is not recommended for severe cases and those with pre-existing cardiac disease… . ”

He said the ministry does not maintain data on using patterns of HCQ by doctors, nurses, health workers and other front-line corona warriors.

The minister gave state-wise break-up on details of HCQ supplied by the government and actual consumption and said that “India has exported the drug to more than 140 countries.”


Re-purposed hydroxychloroquine being used for mild, moderate COVID-19 cases: Health minister

Study to commence: Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: the Hydroxychloroquine Prophylaxis Evaluation(HOPE) trial: A structured summary of a study protocol for a randomized controlled trial

JAMA article affirms benefits of hydroxychloroquine in treating COVID-19

Indian Medical Association endorses prophylactic HCQ use for police force

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Trouble in Paradise Surrounding the use of Ivermectin

In nations around the world tension mounts between physicians and caregivers seeking to prescribe what they professionally deem as safe doses of ivermectin, as an off-label treatment for COVID-19 and national health authorities, which for the most part have all taken a hostile and oppositional position against the use of the drug.

Read More »

How Ivermectin became a Target for the ‘Fraud Detectives.’

And why is ivermectin being so negatively targeted by Big Tech and Big Media? One could argue conflict of interest plays a major role, given how intertwined they are with Big Pharma and the far-reaching grasp of the BMGF. A cheap and effective early treatment for Covid-19, like ivermectin, can be seen as a significant threat to the financial interests of those involved with Covid vaccines and expensive anti-viral drugs.

Read More »

Canada: Alberta Failing on COVID-19 Vaccines and Treatment

Numerous studies and clinical observation of thousands of patients has indicated that Ivermectin is highly effective in this regard. Even low dose studies that were designed to reach the conclusion that ivermectin was not effective found a signal that indicated that Ivermectin effectively interacted with the COVID virus molecule to prevent or lessen replication of the virus.”

Read More »